Atypical antipsychotic withdrawal dyskinesia in 4 patients with mood disorders
Abstract
Department of Psychiatry and Behavioral Science, Eastern Virginia Medical School, Norfolk, VA [email protected]
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Cites
Atypical antipsychotics: Mechanism of action
Seeman, P. (2002) · The Canadian Journal of Psychiatry · doi:10.1177/070674370204700106 · Cited by 899 · see citing works
Correll, C. U., Leucht, S., & Kane, J. M. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.3.414 · Cited by 709 · see citing works
Harrison, T. S., & Perry, C. M. (2004) · Drugs · doi:10.2165/00003495-200464150-00010 · Cited by 276 · see citing works
Samaha, A.-N., Seeman, P., Stewart, J., Rajabi, H., & Kapur, S. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.5416-06.2007 · Cited by 262 · see citing works
Inoue, A., Miki, S., Seto, M., Kikuchi, T., Morita, S., Ueda, H., Misu, Y., & Nakata, Y. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(96)00920-x · Cited by 103 · see citing works
Expected incidence of tardive dyskinesia associated with atypical antipsychotics.
Glazer, W. M. (2000) · PubMed · Cited by 101 · see citing works
Dolder, C. R., & Jeste, D. V. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00170-7 · Cited by 101 · see citing works
Aripiprazole-Induced Improvement in Tardive Dyskinesia
Duggal, H. S. (2003) · The Canadian Journal of Psychiatry · doi:10.1177/070674370304801116 · Cited by 60 · see citing works
Aripiprazole : a review of its use in schizophrenia and schizoaffective disorder
Tracy, Swainston, & Harrison (2004) · Medical Entomology and Zoology · Cited by 49 · see citing works
Aripiprazole-Related Tardive Dyskinesia
Maytal, G., Ostacher, M. J., & Stern, T. A. (2006) · CNS Spectrums · doi:10.1017/s1092852900014632 · Cited by 48 · see citing works
Gharabawi, G. M., Bossie, C. A., Zhu, Y., et al. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2005.03.015 · Cited by 46 · see citing works
Withdrawal-Emergent Dyskinesia in a Patient on Risperidone Undergoing Dosage Reduction
Anand, V., & Dewan, M. J. (1996) · Annals of Clinical Psychiatry · doi:10.3109/10401239609147755 · Cited by 44 · see citing works
Risperidone Withdrawal-Related Respiratory Dyskinesia
Komatsu, S., Kirino, E., Inoue, Y., et al. (2005) · Clinical Neuropharmacology · doi:10.1097/01.wnf.0000161637.81752.b3 · Cited by 21 · see citing works
Aripiprazole-Induced Movement Disorder
Zacher, J. L., & HATCHETT, A. D. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.1.160-a · Cited by 21 · see citing works
A case of Aripiprazole and extra pyramidal side effects
Salmoiraghi, A., & Odiyoor, M. (2006) · Journal of Psychopharmacology · doi:10.1177/0269881106060194 · Cited by 19 · see citing works
Aripiprazole-Associated Dyskinesia
Sajbel, T. A., Cheney, E. M., & DeQuardo, J. R. (2004) · Annals of Pharmacotherapy · doi:10.1345/aph.1e288 · Cited by 14 · see citing works
TREATMENT OF WITHDRAWAL DYSKINESIA
Kafantaris, V., Hirsch, J. A., Saito, E., et al. (2005) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000177329.69462.5f · Cited by 6 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
A Method for Tapering Antipsychotic Treatment That May Minimize the Risk of Relapse
Horowitz, M. A., Jauhar, S., Natesan, S., Murray, R. M., & Taylor, D. (2021) · Schizophrenia Bulletin · doi:10.1093/schbul/sbab017 · Cited by 157 · see citing works
(2010) · Journal of Psychosocial Nursing and Mental Health Services · doi:10.3928/02793695-20100730-04 · Cited by 38 · see citing works
Experiencing antipsychotic discontinuation: results from a survey of <scp>A</scp>ustralian consumers
Salomon, C., Hamilton, B., & Elsom, S. (2014) · Journal of Psychiatric and Mental Health Nursing · doi:10.1111/jpm.12178 · Cited by 25 · see citing works
- Authors
- Urbano, M., Spiegel, D., & Rai, A.
- Affiliations
- Eastern Virginia Medical School (US)
- Venue
- Journal of Clinical Psychopharmacology
- Published
- 2007-12
- Volume
- 27
- Issue
- 6
- Pages
- 705-707
- ISSN
- 0271-0749 (ISSN-L)
- OpenAlex
- W1997434183
- Cited by
- 17
- References
- 17
- Citations by year
- 2024: 1 · 2021: 1 · 2020: 1 · 2017: 1 · 2016: 2 · 2014: 1 · 2013: 2 · 2012: 1
- FWCI
- 1.01
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Clinical Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
- Keywords
- atypical antipsychotics, antipsychotic withdrawal, dyskinesia, mood disorders, tardive dyskinesia, antipsychotic discontinuation
- MeSH terms
- Aripiprazole, Adult, Dyskinesia, Drug-Induced, Female, Humans, Male, Middle Aged, Piperazines, Antipsychotic Agents, Quinolones, Risperidone, Mood Disorders, Withholding Treatment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
